{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:37:44Z","timestamp":1792075064498,"version":"4.4.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"publisher","award":["RTA6180006"],"award-info":[{"award-number":["RTA6180006"]}],"id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Multidrug resistant Enterobacterales have become a serious global health problem, with extended hospital stay and increased mortality. Antibiotic monotherapy has been reported ineffective against most drug resistant bacteria including <jats:italic>Klebsiella pneumoniae<\/jats:italic>, thus encouraging the use of multidrug therapies as an alternative antibacterial strategy. The present works assessed the antibacterial activity of colistin against <jats:italic>K<\/jats:italic>. <jats:italic>pneumoniae<\/jats:italic> isolates. Resistant isolates were tested against 16 conventional antibiotics alone and in combination with colistin. The results revealed that all colistin resistant isolates demonstrated multidrug resistance against the tested antibiotics except amikacin. At sub-inhibitory concentrations, combinations of colistin with amikacin, or fosfomycin showed synergism against 72.72% (8 of 11 isolates). Colistin with either of gentamicin, meropenem, cefoperazone, cefotaxime, ceftazidime, moxifloxacin, minocycline, or piperacillin exhibited synergism against 81.82% (9 of 11 isolates). Combinations of colistin with either of tobramycin or ciprofloxacin showed synergism against 45.45% (5 in 11 isolates), while combinations of colistin with imipenem or ceftolozane and tazobactam displayed 36.36% (4 of 11 isolates) and 63.64% (7 of 11 isolates) synergism. In addition, combinations of colistin with levofloxacin was synergistic against 90.91% (10 of 11 isolates). The results revealed that combinations of colistin with other antibiotics could effectively inhibit colistin resistant isolates of <jats:italic>K<\/jats:italic>. <jats:italic>pneumoniae<\/jats:italic>, and thus could be further explore for the treatment of multidrug resistant pathogens.<\/jats:p>","DOI":"10.1371\/journal.pone.0244673","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T20:46:16Z","timestamp":1609965976000},"page":"e0244673","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":68,"title":["Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates"],"prefix":"10.1371","volume":"16","author":[{"given":"Julalak C.","family":"Ontong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nwabor F.","family":"Ozioma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0949-592X","authenticated-orcid":true,"given":"Supayang P.","family":"Voravuthikunchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3116-2518","authenticated-orcid":true,"given":"Sarunyou","family":"Chusri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"pone.0244673.ref001","volume-title":"No Time to Wait: Securing the future from drug-resistant infections","author":"WHO","year":"2019"},{"issue":"8","key":"pone.0244673.ref002","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1586\/eri.12.78","article-title":"Colistin: an update on the antibiotic of the 21st century","volume":"10","author":"S Biswas","year":"2012","journal-title":"Expert Review of Anti-Infective Therapy"},{"issue":"3","key":"pone.0244673.ref003","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1017\/ice.2019.363","article-title":"Detection of the emergence of mcr-1\u2013mediated colistin-resistant Escherichia coli and Klebsiella pneumoniae through a hospital-based surveillance in an oncology center in eastern India","volume":"41","author":"S Roy","year":"2020","journal-title":"Infection Control & Hospital Epidemiology"},{"issue":"1","key":"pone.0244673.ref004","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12223-019-00709-z","article-title":"The emergence of mcr-1-mediated colistin-resistant Escherichia coli and Klebsiella pneumoniae in domestic and imported turkey meat in the Czech Republic 2017\u20132018","volume":"65","author":"T Gelbicova","year":"2020","journal-title":"Folia Microbiologica"},{"issue":"1","key":"pone.0244673.ref005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/mdr.2018.0014","article-title":"Spread of Carbapenem and Colistin-resistant Klebsiella pneumoniae ST512 clinical isolates in Israel: a cause for vigilance","volume":"25","author":"R Lalaoui","year":"2019","journal-title":"Microbial Drug Resistance"},{"issue":"1","key":"pone.0244673.ref006","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1139\/o03-070","article-title":"Biosynthesis, transport, and modification of lipid A","volume":"82","author":"MS Trent","year":"2004","journal-title":"Biochemistry and Cell Biology"},{"key":"pone.0244673.ref007","first-page":"1","article-title":"Co-existence of a novel plasmid-mediated efflux pump with colistin resistance gene mcr in one plasmid confers transferable multidrug resistance in Klebsiella pneumoniae","author":"S Sun","year":"2020","journal-title":"Emerging Microbes & Infections"},{"issue":"9","key":"pone.0244673.ref008","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1128\/AAC.02284-12","article-title":"KpnEF, a new member of the Klebsiella pneumoniae cell envelope stress response regulon, is an SMR-type efflux pump involved in broad-spectrum antimicrobial resistance","volume":"57","author":"VB Srinivasan","year":"2013","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"pone.0244673.ref009","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.micpath.2016.11.024","article-title":"Efflux mediated colistin resistance in diverse clones of Klebsiella pneumoniae from aquatic environment","volume":"102","author":"SK Singh","year":"2017","journal-title":"Microbial Pathogenesis"},{"issue":"3","key":"pone.0244673.ref010","doi-asserted-by":"crossref","first-page":"105903","DOI":"10.1016\/j.ijantimicag.2020.105903","article-title":"KPC-2-producing Klebsiella pneumoniae ST147 in a neonatal unit: Clonal isolates with differences in colistin susceptibility attributed to AcrAB-TolC pump","volume":"55","author":"S Naha","year":"2020","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"1","key":"pone.0244673.ref011","first-page":"1","article-title":"First report of plasmid-mediated colistin resistance mcr-8.1 gene from a clinical Klebsiella pneumoniae isolate from Lebanon. Antimicrobial Resistance &","volume":"9","author":"T Salloum","journal-title":"Infection Control. 2020"},{"key":"pone.0244673.ref012","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jgar.2019.08.018","article-title":"Development of real-time PCR assay allowed describing the first clinical Klebsiella pneumoniae isolate harboring plasmid-mediated colistin resistance mcr-8 gene in Algeria","volume":"20","author":"LZ Nabti","year":"2020","journal-title":"Journal of Global Antimicrobial Resistance"},{"key":"pone.0244673.ref013","article-title":"Evaluation of polymyxin B in combination with 13 other antibiotics against carbapenemase-producing Klebsiella pneumoniae in time-lapse microscopy and time-kill experiments","author":"P Wistrand-Yuen","year":"2020","journal-title":"Clinical Microbiology and Infection"},{"issue":"4","key":"pone.0244673.ref014","doi-asserted-by":"crossref","first-page":"FSO461","DOI":"10.2144\/fsoa-2019-0074","article-title":"Synergistic activity of fosfomycin\u2013meropenem and fosfomycin\u2013colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence","volume":"6","author":"YD Bakthavatchalam","year":"2020","journal-title":"Future Science OA"},{"key":"pone.0244673.ref015","article-title":"Polymyxin triple combinations against polymyxin-resistant, multidrug-resistant KPC-producing Klebsiella pneumoniae","author":"SM Aye","year":"2020","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"pone.0244673.ref016","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13568-019-0750-4","article-title":"Ursolic acid inhibits colistin efflux and curtails colistin resistant Enterobacteriaceae","volume":"9","author":"NS Sundaramoorthy","year":"2019","journal-title":"AMB Express"},{"issue":"5","key":"pone.0244673.ref017","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1128\/AAC.00248-16","article-title":"Effects of efflux pump inhibitors on colistin resistance in multidrug-resistant Gram-negative bacteria","volume":"60","author":"W Ni","year":"2016","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"7","key":"pone.0244673.ref018","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/jac\/dky134","article-title":"Efflux pump inhibitor CCCP to rescue colistin susceptibility in mcr-1 plasmid-mediated colistin-resistant strains and Gram-negative bacteria","volume":"73","author":"SA Baron","year":"2018","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"pone.0244673.ref019","article-title":"Circumventing colistin resistance by combining colistin and antimicrobial peptides to kill colistin-resistant and multidrug-resistant Gram-negative bacteria","author":"KS Witherell","year":"2020","journal-title":"Journal of Global Antimicrobial Resistance"},{"issue":"8","key":"pone.0244673.ref020","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00292-17","article-title":"Susceptibility of colistin-resistant, Gram-negative bacteria to antimicrobial peptides and ceragenins","volume":"61","author":"MM Hashemi","year":"2017","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"pone.0244673.ref021","volume-title":"M100S","author":"CLSI","year":"2016"},{"key":"pone.0244673.ref022","unstructured":"EUCAST. \"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. European Society of Clinical Microbiology and Infectious Diseases. Version 10.0; 2020."},{"key":"pone.0244673.ref023","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/IDR.S182585","article-title":"In vitro activity of colistin in combination with various antimicrobials against Acinetobacter baumannii species, a report from South Iran","volume":"12","author":"R Kheshti","year":"2019","journal-title":"Infection and Drug Resistance"},{"issue":"8","key":"pone.0244673.ref024","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s10096-015-2401-2","article-title":"An outbreak of colistin-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the Netherlands (July to December 2013), with inter-institutional spread","volume":"34","author":"V Weterings","year":"2015","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"issue":"6","key":"pone.0244673.ref025","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ijantimicag.2014.07.020","article-title":"Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP\/PhoQ regulator mgrB: an epidemiological and molecular study","volume":"44","author":"AO Olaitan","year":"2014","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"2","key":"pone.0244673.ref026","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1128\/AAC.01020-10","article-title":"Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan","volume":"55","author":"D Marchaim","year":"2011","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"pone.0244673.ref027","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jgar.2018.06.007","article-title":"Prevalence of the colistin resistance gene mcr-1 in colistin-resistant Escherichia coli and Klebsiella pneumoniae isolated from humans in Thailand","volume":"15","author":"W Eiamphungporn","year":"2018","journal-title":"Journal of Global Antimicrobial Resistance"},{"issue":"5","key":"pone.0244673.ref028","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02549-18","article-title":"Evaluation of the bactericidal activity of fosfomycin in combination with selected antimicrobial comparison agents tested against gram-negative bacterial strains by using time-kill curves","volume":"63","author":"RK Flamm","year":"2019","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"pone.0244673.ref029","volume-title":"Performance standards for antimicrobial susceptibility testing","author":"CLSI","year":"2017"},{"issue":"2","key":"pone.0244673.ref030","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1089\/mdr.2018.0398","article-title":"In Vitro Antimicrobial Susceptibility Differences Between Carbapenem-Resistant KPC-2-Producing and NDM-1-Producing Klebsiella pneumoniae in a Teaching Hospital in Northeast China","volume":"26","author":"L Lin","year":"2020","journal-title":"Microbial Drug Resistance"},{"issue":"5","key":"pone.0244673.ref031","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00012-20","article-title":"ARGONAUT II study of the in vitro activity of plazomicin against carbapenemase-producing Klebsiella pneumoniae","volume":"64","author":"MR Jacobs","year":"2020","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"pone.0244673.ref032","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/IDR.S189494","article-title":"Emergence and molecular characterization of multidrug-resistant Klebsiella pneumoniae isolates harboring blaCTX-M-15 extended-spectrum \u03b2-lactamases causing ventilator-associated pneumonia in China","volume":"12","author":"H Xu","year":"2019","journal-title":"Infection and Drug Resistance"},{"key":"pone.0244673.ref033","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3389\/fmicb.2019.01669","article-title":"Molecular epidemiology of multidrug-resistant Klebsiella pneumoniae isolates in a Brazilian tertiary hospital","volume":"10","author":"JK Palmeiro","year":"2019","journal-title":"Frontiers in Microbiology"},{"key":"pone.0244673.ref034","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3389\/fcimb.2019.00422","article-title":"Synergetic effects of combined treatment of colistin with meropenem or amikacin on carbapenem-resistant Klebsiella pneumoniae in vitro","volume":"9","author":"L Yu","year":"2019","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"key":"pone.0244673.ref035","article-title":"Investigation of the In Vitro Effectiveness of Aztreonam\/Avibactam, Colistin\/Apramycin, and Meropenem\/Apramycin Combinations Against Carbapenemase-Producing, Extensively Drug-Resistant Klebsiella pneumoniae Strains","author":"U Kilic","year":"2020","journal-title":"Microbial Drug Resistance"},{"issue":"1","key":"pone.0244673.ref036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13756-020-00727-4","article-title":"In vitro evaluation of double carbapenem and colistin combinations against OXA-48, NDM carbapenemase-producing colistin-resistant Klebsiella pneumoniae strains","volume":"9","author":"F Erdem","year":"2020","journal-title":"Antimicrobial Resistance & Infection Control"},{"issue":"8","key":"pone.0244673.ref037","doi-asserted-by":"crossref","first-page":"e00779","DOI":"10.1128\/AAC.00779-19","article-title":"Evaluation of the synergy of ceftazidime-avibactam in combination with meropenem, amikacin, aztreonam, colistin, or fosfomycin against well-characterized multidrug-resistant Klebsiella pneumoniae and Pseudomonas aeruginosa","volume":"63","author":"S Mikhail","year":"2019","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"pone.0244673.ref038","article-title":"In vitro activity of polymyxin B in combination with meropenem, amikacin and gentamicin against Klebsiella pneumoniae clinical isolates coharboring AMEs, blaNDM-1 and blaKPC-2","author":"EF Firmo","year":"2020","journal-title":"Journal of Global Antimicrobial Resistance"},{"key":"pone.0244673.ref039","first-page":"1","article-title":"In vitro synergistic activity of fosfomycin in combination with meropenem, amikacin and colistin against OXA-48 and\/or NDM-producing Klebsiella pneumoniae","volume":"2020","author":"B Erturk Sengel","journal-title":"Journal of Chemotherapy"},{"issue":"6","key":"pone.0244673.ref040","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s10096-019-03517-y","article-title":"In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015\u20132016","volume":"38","author":"I Galani","year":"2019","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"issue":"11","key":"pone.0244673.ref041","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1093\/jac\/dkz354","article-title":"Activity of imipenem\/relebactam against carbapenemase-producing Enterobacteriaceae with high colistin resistance","volume":"74","author":"J Carpenter","year":"2019","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"4","key":"pone.0244673.ref042","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02542-19","article-title":"Efficacy of Ceftolozane-Tazobactam in Combination with Colistin against Extensively Drug-Resistant Pseudomonas aeruginosa, Including High-Risk Clones, in an In Vitro Pharmacodynamic Model","volume":"64","author":"M Montero","year":"2020","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"pone.0244673.ref043","first-page":"1","article-title":"Synergistic activities of ceftazidime-avibactam in combination with different antibiotics against colistin-nonsusceptible clinical strains of Pseudomonas aeruginosa","volume":"2020","author":"E Mataraci Kara","journal-title":"Infectious Diseases"},{"key":"pone.0244673.ref044","first-page":"1","article-title":"Evaluation of the synergy of ceftazidime\/avibactam in combination with colistin, doripenem, levofloxacin, tigecycline, and tobramycin against OXA-48 producing Enterobacterales","volume":"2020","author":"E Mataraci Kara","journal-title":"Journal of Chemotherapy"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0251994","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:00:00Z","timestamp":1620950400000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0244673","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T20:47:30Z","timestamp":1609966050000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0244673"}},"subtitle":[],"editor":[{"given":"Iddya","family":"Karunasagar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,1,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0244673","relation":{"correction":[{"id-type":"doi","id":"10.1371\/journal.pone.0251994","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]}}}